Glucotrack Announces Publication of Study on Continuous Blood Glucose Monitoring Technology

Glucotrack, Inc. announced the publication of a peer-reviewed study demonstrating the long-term accuracy and stability of its continuous blood glucose monitoring (CBGM) technology in an ovine model. The study showed excellent accuracy with a weighted average Mean Absolute Relative Difference (MARD) of 6.8% over 240 days, with no adverse safety events. The company aims to further develop this technology toward clinical use and commercialization, following promising results from previous studies.